243 related articles for article (PubMed ID: 19356370)
1. NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease.
Svensson M; Gorst-Rasmussen A; Schmidt EB; Jorgensen KA; Christensen JH
Clin Nephrol; 2009 Apr; 71(4):380-6. PubMed ID: 19356370
[TBL] [Abstract][Full Text] [Related]
2. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
3. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
[TBL] [Abstract][Full Text] [Related]
4. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
[TBL] [Abstract][Full Text] [Related]
10. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
[TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
[TBL] [Abstract][Full Text] [Related]
13. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
15. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA
Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
[TBL] [Abstract][Full Text] [Related]
17. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
[TBL] [Abstract][Full Text] [Related]
19. Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.
Cui H; Huo G; Liu L; Fan L; Ye P; Cao J; Bai Y; Wang F; Hu Y
BMC Cardiovasc Disord; 2012 Jul; 12():57. PubMed ID: 22834778
[TBL] [Abstract][Full Text] [Related]
20. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
